Radiation Oncology · 2020 · 37 citations · 28 references
MedicineOncologyRadiation OncologyClinical Radiation OncologyThoracic OncologyTreatment PlanningCancer Treatment PlanningLung CancerOrgans At RiskRadiation TherapyRadiation Treatment PlanningStereotactic RadiotherapyClinical Constraint PrioritizationClinical Target Volume CoverageConstraintsLung Dose ConstraintsOptimal Dose SelectionOrgan-at-risk ConstraintsRadiotherapy Plan EvaluationTarget Coverage
BACKGROUND: For stereotactic body radiotherapy (SBRT) to central (C) and ultracentral (UC) lung tumors, our provincial practice has been to prioritize organs at risk (OARs) constraints by compromising target volume coverage if needed. The objectives are to report the treatment's efficacy and safety. METHODS: We conducted a retrospective analysis of all provincial patients who underwent SBRT at 60Gy in 8 fractions to C and UC lung tumors, from 2013 to 2017. RESULTS: Ninety-eight lesions were treated, 57 (58.2%) C and 41 (41.8%) UC. The median follow-up was 22.9 months (range 2.5-64.8 months). The 1- and 3-year local control (LC) was 97.8 and 84.5% respectively, with no differences between C and UC groups (p = 0.662). Fifty-three (54.1%) cases had optimal dose coverage (V60Gy ITV&PTV > 95%), 29 (29.6%) had compromised PTV coverage (V60Gy ITV > 95%/PTV < 95%), and 16 (16.3%) had both compromised ITV and PTV coverage (V60Gy ITV&PTV < 95%). No significant difference in LC was detected at 2 years between the 3 groups (95.6, 91.8 and 90.9%, p = 0.717). There were 3 episodes of grade 3 toxicity in the C group (2 dyspnea, 1 pneumonitis) and 2 in the UC group (1 dyspnea, 1 hemoptysis). There were no gr4/5 toxicities. On multivariable Cox regression analysis, ITV size was found to be a predictor for LC (p = 0.001). CONCLUSIONS: SBRT at 60Gy in 8 fractions achieves high rates of LC with low risks of significant toxicities, even if target volume coverage is reduced to meet OARs constraints.
28
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Robert Timmerman · JAMA · 2010 · 2.5K citations · Full text
Stereotactic body radiation therapy: The report of AAPM Task Group 101
Stanley Benedict, Kamil M. Yenice, D Followill et al. · Medical Physics · 2010 · 2.2K citations · Full text
David A. Palma, Robert Olson, Stephen Harrow et al. · The Lancet · 2019 · 1.9K citations
Robert Timmerman, Ronald C. McGarry, Constantin T. Yiannoutsos et al. · Journal of Clinical Oncology · 2006 · 1.5K citations · Full text
Medicine, Radiation Oncology, Clinical Radiation Oncology +16
Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma
Hiroshi Onishi, Tsutomu Araki, Hiroki Shirato et al. · Cancer · 2004 · 906 citations · Full text